Table of Contents Global Choroidal Neovascularization Drug Market Professional Survey Report 2018 1 Industry Overview of Choroidal Neovascularization Drug 1.1 Definition and Specifications of Choroidal Neovascularization Drug 1.1.1 Definition of Choroidal Neovascularization Drug 1.1.2 Specifications of Choroidal Neovascularization Drug 1.2 Classification of Choroidal Neovascularization Drug 1.2.1 AVMOC-001 1.2.2 BB-3 1.2.3 BBT-007 1.2.4 DG-3 1.2.5 Entolimod 1.2.6 EWA-001 1.2.7 Others 1.3 Applications of Choroidal Neovascularization Drug 1.3.1 Clinic 1.3.2 Hospital 1.3.3 Others 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 Southeast Asia 1.4.6 India 2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug 2.3 Manufacturing Process Analysis of Choroidal Neovascularization Drug 2.4 Industry Chain Structure of Choroidal Neovascularization Drug 3 Technical Data and Manufacturing Plants Analysis of Choroidal Neovascularization Drug 3.1 Capacity and Commercial Production Date of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 3.2 Manufacturing Plants Distribution of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 3.3 R&D Status and Technology Source of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 3.4 Raw Materials Sources Analysis of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 4 Global Choroidal Neovascularization Drug Overall Market Overview 4.1 2013-2018E Overall Market Analysis 4.2 Capacity Analysis 4.2.1 2013-2018E Global Choroidal Neovascularization Drug Capacity and Growth Rate Analysis 4.2.2 2017 Choroidal Neovascularization Drug Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2013-2018E Global Choroidal Neovascularization Drug Sales and Growth Rate Analysis 4.3.2 2017 Choroidal Neovascularization Drug Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2013-2018E Global Choroidal Neovascularization Drug Sales Price 4.4.2 2017 Choroidal Neovascularization Drug Sales Price Analysis (Company Segment) 5 Choroidal Neovascularization Drug Regional Market Analysis 5.1 North America Choroidal Neovascularization Drug Market Analysis 5.1.1 North America Choroidal Neovascularization Drug Market Overview 5.1.2 North America 2013-2018E Choroidal Neovascularization Drug Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2013-2018E Choroidal Neovascularization Drug Sales Price Analysis 5.1.4 North America 2017 Choroidal Neovascularization Drug Market Share Analysis 5.2 Europe Choroidal Neovascularization Drug Market Analysis 5.2.1 Europe Choroidal Neovascularization Drug Market Overview 5.2.2 Europe 2013-2018E Choroidal Neovascularization Drug Local Supply, Import, Export, Local Consumption Analysis 5.2.3 Europe 2013-2018E Choroidal Neovascularization Drug Sales Price Analysis 5.2.4 Europe 2017 Choroidal Neovascularization Drug Market Share Analysis 5.3 China Choroidal Neovascularization Drug Market Analysis 5.3.1 China Choroidal Neovascularization Drug Market Overview 5.3.2 China 2013-2018E Choroidal Neovascularization Drug Local Supply, Import, Export, Local Consumption Analysis 5.3.3 China 2013-2018E Choroidal Neovascularization Drug Sales Price Analysis 5.3.4 China 2017 Choroidal Neovascularization Drug Market Share Analysis 5.4 Japan Choroidal Neovascularization Drug Market Analysis 5.4.1 Japan Choroidal Neovascularization Drug Market Overview 5.4.2 Japan 2013-2018E Choroidal Neovascularization Drug Local Supply, Import, Export, Local Consumption Analysis 5.4.3 Japan 2013-2018E Choroidal Neovascularization Drug Sales Price Analysis 5.4.4 Japan 2017 Choroidal Neovascularization Drug Market Share Analysis 5.5 Southeast Asia Choroidal Neovascularization Drug Market Analysis 5.5.1 Southeast Asia Choroidal Neovascularization Drug Market Overview 5.5.2 Southeast Asia 2013-2018E Choroidal Neovascularization Drug Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Southeast Asia 2013-2018E Choroidal Neovascularization Drug Sales Price Analysis 5.5.4 Southeast Asia 2017 Choroidal Neovascularization Drug Market Share Analysis 5.6 India Choroidal Neovascularization Drug Market Analysis 5.6.1 India Choroidal Neovascularization Drug Market Overview 5.6.2 India 2013-2018E Choroidal Neovascularization Drug Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2013-2018E Choroidal Neovascularization Drug Sales Price Analysis 5.6.4 India 2017 Choroidal Neovascularization Drug Market Share Analysis 6 Global 2013-2018E Choroidal Neovascularization Drug Segment Market Analysis (by Type) 6.1 Global 2013-2018E Choroidal Neovascularization Drug Sales by Type 6.2 Different Types of Choroidal Neovascularization Drug Product Interview Price Analysis 6.3 Different Types of Choroidal Neovascularization Drug Product Driving Factors Analysis 6.3.1 AVMOC-001 of Choroidal Neovascularization Drug Growth Driving Factor Analysis 6.3.2 BB-3 of Choroidal Neovascularization Drug Growth Driving Factor Analysis 6.3.3 BBT-007 of Choroidal Neovascularization Drug Growth Driving Factor Analysis 6.3.4 DG-3 of Choroidal Neovascularization Drug Growth Driving Factor Analysis 6.3.5 Entolimod of Choroidal Neovascularization Drug Growth Driving Factor Analysis 6.3.6 EWA-001 of Choroidal Neovascularization Drug Growth Driving Factor Analysis 6.3.7 Others of Choroidal Neovascularization Drug Growth Driving Factor Analysis 7 Global 2013-2018E Choroidal Neovascularization Drug Segment Market Analysis (by Application) 7.1 Global 2013-2018E Choroidal Neovascularization Drug Consumption by Application 7.2 Different Application of Choroidal Neovascularization Drug Product Interview Price Analysis 7.3 Different Application of Choroidal Neovascularization Drug Product Driving Factors Analysis 7.3.1 Clinic of Choroidal Neovascularization Drug Growth Driving Factor Analysis 7.3.2 Hospital of Choroidal Neovascularization Drug Growth Driving Factor Analysis 7.3.3 Others of Choroidal Neovascularization Drug Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Choroidal Neovascularization Drug 8.1 Cellphire, Inc. 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Cellphire, Inc. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Cellphire, Inc. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.2 Chrysalis BioTherapeutics, Inc. 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Chrysalis BioTherapeutics, Inc. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Chrysalis BioTherapeutics, Inc. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.3 Cleveland BioLabs, Inc. 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Cleveland BioLabs, Inc. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Cleveland BioLabs, Inc. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.4 Cumberland Pharmaceuticals, Inc. 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Cumberland Pharmaceuticals, Inc. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Cumberland Pharmaceuticals, Inc. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.5 Diffusion Pharmaceuticals Inc. 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Diffusion Pharmaceuticals Inc. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Diffusion Pharmaceuticals Inc. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.6 Eli Lilly and Company 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Eli Lilly and Company 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Eli Lilly and Company 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.7 GNI Group Ltd. 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 GNI Group Ltd. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 GNI Group Ltd. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.8 Humanetics Corporation 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 Humanetics Corporation 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Humanetics Corporation 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.9 INSYS Therapeutics, Inc. 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 INSYS Therapeutics, Inc. 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 INSYS Therapeutics, Inc. 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.10 Meabco A/S 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Product A 8.10.2.2 Product B 8.10.3 Meabco A/S 2017 Choroidal Neovascularization Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Meabco A/S 2017 Choroidal Neovascularization Drug Business Region Distribution Analysis 8.11 Neumedicines Inc. 8.12 Onconova Therapeutics, Inc. 8.13 PharmaIN Corporation 8.14 Pluristem Therapeutics Inc. 8.15 ProCertus BioPharm Inc. 8.16 RDD Pharma Ltd. 8.17 RedHill Biopharma Ltd. 8.18 RxBio, Inc. 8.19 Soligenix, Inc. 9 Development Trend of Analysis of Choroidal Neovascularization Drug Market 9.1 Global Choroidal Neovascularization Drug Market Trend Analysis 9.1.1 Global 2018-2025 Choroidal Neovascularization Drug Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2025 Choroidal Neovascularization Drug Sales Price Forecast 9.2 Choroidal Neovascularization Drug Regional Market Trend 9.2.1 North America 2018-2025 Choroidal Neovascularization Drug Consumption Forecast 9.2.2 Europe 2018-2025 Choroidal Neovascularization Drug Consumption Forecast 9.2.3 China 2018-2025 Choroidal Neovascularization Drug Consumption Forecast 9.2.4 Japan 2018-2025 Choroidal Neovascularization Drug Consumption Forecast 9.2.5 Southeast Asia 2018-2025 Choroidal Neovascularization Drug Consumption Forecast 9.2.6 India 2018-2025 Choroidal Neovascularization Drug Consumption Forecast 9.3 Choroidal Neovascularization Drug Market Trend (Product Type) 9.4 Choroidal Neovascularization Drug Market Trend (Application) 10 Choroidal Neovascularization Drug Marketing Type Analysis 10.1 Choroidal Neovascularization Drug Regional Marketing Type Analysis 10.2 Choroidal Neovascularization Drug International Trade Type Analysis 10.3 Traders or Distributors with Contact Information of Choroidal Neovascularization Drug by Region 10.4 Choroidal Neovascularization Drug Supply Chain Analysis 11 Consumers Analysis of Choroidal Neovascularization Drug 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis 12 Conclusion of the Global Choroidal Neovascularization Drug Market Professional Survey Report 2017 Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Picture of Choroidal Neovascularization Drug Table Product Specifications of Choroidal Neovascularization Drug Table Classification of Choroidal Neovascularization Drug Figure Global Production Market Share of Choroidal Neovascularization Drug by Type in 2017 Figure AVMOC-001 Picture Table Major Manufacturers of AVMOC-001 Figure BB-3 Picture Table Major Manufacturers of BB-3 Figure BBT-007 Picture Table Major Manufacturers of BBT-007 Figure DG-3 Picture Table Major Manufacturers of DG-3 Figure Entolimod Picture Table Major Manufacturers of Entolimod Figure EWA-001 Picture Table Major Manufacturers of EWA-001 Figure Others Picture Table Major Manufacturers of Others Table Applications of Choroidal Neovascularization Drug Figure Global Consumption Volume Market Share of Choroidal Neovascularization Drug by Application in 2017 Figure Clinic Examples Table Major Consumers in Clinic Figure Hospital Examples Table Major Consumers in Hospital Figure Others Examples Table Major Consumers in Others Figure Market Share of Choroidal Neovascularization Drug by Regions Figure North America Choroidal Neovascularization Drug Market Size (Million USD) (2013-2025) Figure Europe Choroidal Neovascularization Drug Market Size (Million USD) (2013-2025) Figure China Choroidal Neovascularization Drug Market Size (Million USD) (2013-2025) Figure Japan Choroidal Neovascularization Drug Market Size (Million USD) (2013-2025) Figure Southeast Asia Choroidal Neovascularization Drug Market Size (Million USD) (2013-2025) Figure India Choroidal Neovascularization Drug Market Size (Million USD) (2013-2025) Table Choroidal Neovascularization Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Choroidal Neovascularization Drug in 2017 Figure Manufacturing Process Analysis of Choroidal Neovascularization Drug Figure Industry Chain Structure of Choroidal Neovascularization Drug Table Capacity and Commercial Production Date of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 Table Manufacturing Plants Distribution of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 Table R&D Status and Technology Source of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 Table Raw Materials Sources Analysis of Global Choroidal Neovascularization Drug Major Manufacturers in 2017 Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Choroidal Neovascularization Drug 2013-2018E Figure Global 2013-2018E Choroidal Neovascularization Drug Market Size (Volume) and Growth Rate Figure Global 2013-2018E Choroidal Neovascularization Drug Market Size (Value) and Growth Rate Table 2013-2018E Global Choroidal Neovascularization Drug Capacity and Growth Rate Table 2017 Global Choroidal Neovascularization Drug Capacity (K Pcs) List (Company Segment) Table 2013-2018E Global Choroidal Neovascularization Drug Sales (K Pcs) and Growth Rate Table 2017 Global Choroidal Neovascularization Drug Sales (K Pcs) List (Company Segment) Table 2013-2018E Global Choroidal Neovascularization Drug Sales Price (USD/Pcs) Table 2017 Global Choroidal Neovascularization Drug Sales Price (USD/Pcs) List (Company Segment) Figure North America Capacity Overview Table North America Supply, Import, Export and Consumption (K Pcs) of Choroidal Neovascularization Drug 2013-2018E Figure North America 2013-2018E Choroidal Neovascularization Drug Sales Price (USD/Pcs) Figure North America 2017 Choroidal Neovascularization Drug Sales Market Share Figure Europe Capacity Overview Table Europe Supply, Import, Export and Consumption (K Pcs) of Choroidal Neovascularization Drug 2013-2018E Figure Europe 2013-2018E Choroidal Neovascularization Drug Sales Price (USD/Pcs) Figure Europe 2017 Choroidal Neovascularization Drug Sales Market Share Figure China Capacity Overview Table China Supply, Import, Export and Consumption (K Pcs) of Choroidal Neovascularization Drug 2013-2018E Figure China 2013-2018E Choroidal Neovascularization Drug Sales Price (USD/Pcs) Figure China 2017 Choroidal Neovascularization Drug Sales Market Share Figure Japan Capacity Overview Table Japan Supply, Import, Export and Consumption (K Pcs) of Choroidal Neovascularization Drug 2013-2018E Figure Japan 2013-2018E Choroidal Neovascularization Drug Sales Price (USD/Pcs) Figure Japan 2017 Choroidal Neovascularization Drug Sales Market Share Figure Southeast Asia Capacity Overview Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Choroidal Neovascularization Drug 2013-2018E Figure Southeast Asia 2013-2018E Choroidal Neovascularization Drug Sales Price (USD/Pcs) Figure Southeast Asia 2017 Choroidal Neovascularization Drug Sales Market Share Figure India Capacity Overview Table India Supply, Import, Export and Consumption (K Pcs) of Choroidal Neovascularization Drug 2013-2018E Figure India 2013-2018E Choroidal Neovascularization Drug Sales Price (USD/Pcs) Figure India 2017 Choroidal Neovascularization Drug Sales Market Share Table Global 2013-2018E Choroidal Neovascularization Drug Sales (K Pcs) by Type Table Different Types Choroidal Neovascularization Drug Product Interview Price Table Global 2013-2018E Choroidal Neovascularization Drug Sales (K Pcs) by Application Table Different Application Choroidal Neovascularization Drug Product Interview Price Table Cellphire, Inc. Information List Table Product A Overview Table Product B Overview Table 2017 Cellphire, Inc. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Cellphire, Inc. Choroidal Neovascularization Drug Business Region Distribution Table Chrysalis BioTherapeutics, Inc. Information List Table Product A Overview Table Product B Overview Table 2017 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Business Region Distribution Table Cleveland BioLabs, Inc. Information List Table Product A Overview Table Product B Overview Table 2015 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Business Region Distribution Table Cumberland Pharmaceuticals, Inc. Information List Table Product A Overview Table Product B Overview Table 2017 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Business Region Distribution Table Diffusion Pharmaceuticals Inc. Information List Table Product A Overview Table Product B Overview Table 2017 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Business Region Distribution Table Eli Lilly and Company Information List Table Product A Overview Table Product B Overview Table 2017 Eli Lilly and Company Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Eli Lilly and Company Choroidal Neovascularization Drug Business Region Distribution Table GNI Group Ltd. Information List Table Product A Overview Table Product B Overview Table 2017 GNI Group Ltd. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 GNI Group Ltd. Choroidal Neovascularization Drug Business Region Distribution Table Humanetics Corporation Information List Table Product A Overview Table Product B Overview Table 2017 Humanetics Corporation Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Humanetics Corporation Choroidal Neovascularization Drug Business Region Distribution Table INSYS Therapeutics, Inc. Information List Table Product A Overview Table Product B Overview Table 2017 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Business Region Distribution Table Meabco A/S Information List Table Product A Overview Table Product B Overview Table 2017 Meabco A/S Choroidal Neovascularization Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs) Figure 2017 Meabco A/S Choroidal Neovascularization Drug Business Region Distribution Table Neumedicines Inc. Information List Table Onconova Therapeutics, Inc. Information List Table PharmaIN Corporation Information List Table Pluristem Therapeutics Inc. Information List Table ProCertus BioPharm Inc. Information List Table RDD Pharma Ltd. Information List Table RedHill Biopharma Ltd. Information List Table RxBio, Inc. Information List Table Soligenix, Inc. Information List Figure Global 2018-2025 Choroidal Neovascularization Drug Market Size (K Pcs) and Growth Rate Forecast Figure Global 2018-2025 Choroidal Neovascularization Drug Market Size (Million USD) and Growth Rate Forecast Figure Global 2018-2025 Choroidal Neovascularization Drug Sales Price (USD/Pcs) Forecast Figure North America 2018-2025 Choroidal Neovascularization Drug Consumption Volume (K Pcs) and Growth Rate Forecast Figure China 2018-2025 Choroidal Neovascularization Drug Consumption Volume (K Pcs) and Growth Rate Forecast Figure Europe 2018-2025 Choroidal Neovascularization Drug Consumption Volume (K Pcs) and Growth Rate Forecast Figure Southeast Asia 2018-2025 Choroidal Neovascularization Drug Consumption Volume (K Pcs) and Growth Rate Forecast Figure Japan 2018-2025 Choroidal Neovascularization Drug Consumption Volume (K Pcs) and Growth Rate Forecast Figure India 2018-2025 Choroidal Neovascularization Drug Consumption Volume (K Pcs) and Growth Rate Forecast Table Global Sales Volume (K Pcs) of Choroidal Neovascularization Drug by Type 2018-2025 Table Global Consumption Volume (K Pcs) of Choroidal Neovascularization Drug by Application 2018-2025 Table Traders or Distributors with Contact Information of Choroidal Neovascularization Drug by Region